Melatonin Supplementation as adjuvant Therapy for Prevention of Bronchopulmonary Dysplasia in Neonates

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

TCTR

Registry ID

TCTR20191211004

Enrollment

Unknown

Registered

2019-12-11

Start date

2016-07-06

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bronchopulmonary dysplasia bronchopulmonary dysplasia

Interventions

melatonin,follow up

Experimental Drug,Experimental No treatment

BPD group,non&#45

BPD group

Eligibility

Sex/Gender

All

Age

28 Days to 80 Days

Inclusion criteria

Inclusion criteria: preterm neonates

Exclusion criteria

Exclusion criteria: full term neonates

Design outcomes

Primary

Measure	Time frame
BPD 28 days ELISA	—

Secondary

Measure	Time frame
N/A N/A N/A	—

Countries

Egypt

Contacts

Public ContactDina adam

Tanta university hospital lecturer of clinical pathology,

dr.dinaadam012@gmail.com0020127940773

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026